Skip to main content
Log in

Leitfaden

Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen

Statin-associated muscle symptoms

  • FORTBILDUNG . SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Das Problem Statin-assoziierter Muskelschmerzen und damit die Sorge, dass Ihrem Patienten das präventive Potenzial der Statintherapie entgeht, kennen Sie sicherlich auch. Der nachfolgende Beitrag zeigt auf, wie Sie das Problem Schritt für Schritt in den Griff bekommen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Yusuf S, Why do people not take life-saving medications? The case of statins. Lancet. 2016 Sep 3;388(10048):943–5

    Article  PubMed  Google Scholar 

  2. Collins R et al., Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532–2561

    Article  CAS  PubMed  Google Scholar 

  3. Stroes ES et al., Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015 May 1;36(17):1012–22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hovingh GK et al., Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey. Atherosclerosis. 2016 Feb;245:111–7

    Article  CAS  PubMed  Google Scholar 

  5. Laufs U et al, Behandlungsoptionen bei Statin-assoziierten Muskelbeschwerden. Dtsch Ärztebl Int. 2015 Oct 30;112(44):748–55

    PubMed  PubMed Central  Google Scholar 

  6. Parker BA et al., Effect of statins on skeletal muscle function. Circulation. 2013 Jan 1;127(1):96–103

    Article  CAS  PubMed  Google Scholar 

  7. Moriarty PM et al., Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol. 2015 Nov-Dec;9(6):758–769

    Article  PubMed  Google Scholar 

  8. Nissen SE et al., Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. JAMA. 2016 Apr 19;315(15):1580–90

    Article  CAS  PubMed  Google Scholar 

  9. Gupta A et al., Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017 Jun 24;389(10088):2473–2481

    Article  CAS  PubMed  Google Scholar 

  10. 2014 arznei-telegramm, publiziert am 9. Mai 2014

  11. Laufs U et al., Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl. 2017 Apr;26:45–55

    Article  PubMed  Google Scholar 

  12. du Souich P et al, Myotoxicity of statins: Mechanism of action. Pharmacol Ther. 2017 Jul;175:1–16

    Article  PubMed  Google Scholar 

  13. Cholesterol Treatment Trialists’ (CTT) Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010 Nov 13;376(9753):1670–81

    Article  Google Scholar 

  14. Daskalopoulou SS et al, Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. 2008 Sep;29(17):2083–91

    Article  PubMed  Google Scholar 

  15. Shalev V et al., Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med. 2009 Feb 9;169(3):260–8

    Article  PubMed  Google Scholar 

  16. Turner RM et al., Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome. J Clin Lipidol. 2017 Jan - Feb;11(1):204–214

    Article  PubMed  PubMed Central  Google Scholar 

  17. Serban MC et al., Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. J Am Coll Cardiol. 2017 Mar 21;69(11):1386–1395

    Article  CAS  PubMed  Google Scholar 

  18. Nissen SE, Statin Denial: An Internet-Driven Cult With Deadly Consequences. Ann Intern Med. 2017 Aug 15;167(4):281–282

    Article  PubMed  Google Scholar 

  19. Nielsen SF et al., Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. Eur Heart J. 2016 Mar 14;37(11):908–916

    Article  PubMed  Google Scholar 

  20. Landmesser, U et al., 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. Eur Heart J. 2017 Oct 16 doi: 10.1093/eurheartj/ehx549. [Epub ahead of print

  21. Irvin JC The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Pharmacological Research 2017

  22. Khayznikov M et al., Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation. N Am J Med Sci. 2015 Mar;7(3):86–93

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerald Klose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klose, G. Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen. MMW - Fortschritte der Medizin 160, 40–43 (2018). https://doi.org/10.1007/s15006-018-0090-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-0090-3

Keywords

Navigation